Literature DB >> 24484981

Dopamine D4 receptors in psychostimulant addiction.

Patricia Di Ciano1, David K Grandy2, Bernard Le Foll3.   

Abstract

Since the cloning of the D4 receptor in the 1990s, interest has been building in the role of this receptor in drug addiction, given the importance of dopamine in addiction. Like the D3 receptor, the D4 receptor has limited distribution within the brain, suggesting it may have a unique role in drug abuse. However, compared to the D3 receptor, few studies have evaluated the importance of the D4 receptor. This may be due, in part, to the relative lack of compounds selective for the D4 receptor; the early studies were mainly conducted in mice lacking the D4 receptor. In this review, we summarize the literature on the structure and localization of the D4 receptor before reviewing the data from D4 knockout mice that used behavioral models relevant to the understanding of stimulant use. We also present evidence from more recent pharmacological studies using selective D4 agonists and antagonists and animal models of drug-seeking and drug-taking. The data summarized here suggest a role for D4 receptors in relapse to stimulant use. Therefore, treatments based on antagonism of the D4 receptor may be useful treatments for relapse to nicotine, cocaine, and amphetamine use.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amphetamine; Cocaine; D4; Dopamine; Nicotine; Smoking

Mesh:

Substances:

Year:  2014        PMID: 24484981      PMCID: PMC4410854          DOI: 10.1016/B978-0-12-420118-7.00008-1

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  96 in total

1.  DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues.

Authors:  F Joseph McClernon; Kent E Hutchison; Jed E Rose; Rachel V Kozink
Journal:  Psychopharmacology (Berl)       Date:  2007-07-05       Impact factor: 4.530

2.  Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.

Authors:  Jack Bergman; Rebecca A Roof; Cheryse A Furman; Jennie L Conroy; Nancy K Mello; David R Sibley; Phil Skolnick
Journal:  Int J Neuropsychopharmacol       Date:  2012-07-25       Impact factor: 5.176

3.  Nicotine reinstatement of nicotine self-administration after long-term extinction.

Authors:  C Chiamulera; C Borgo; S Falchetto; E Valerio; M Tessari
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

4.  Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking?

Authors:  Manfred Laucht; Katja Becker; Mahha El-Faddagh; Erika Hohm; Martin H Schmidt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-05       Impact factor: 8.829

5.  Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation.

Authors:  F J Monsma; L C Mahan; L D McVittie; C R Gerfen; D R Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 6.  Genetics of dopamine receptors and drug addiction: a comprehensive review.

Authors:  Bernard Le Foll; Alexandra Gallo; Yann Le Strat; Lin Lu; Philip Gorwood
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

7.  The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus.

Authors:  F M Chang; J R Kidd; K J Livak; A J Pakstis; K K Kidd
Journal:  Hum Genet       Date:  1996-07       Impact factor: 4.132

8.  The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations.

Authors:  D L Feldpausch; L M Needham; M P Stone; J S Althaus; B K Yamamoto; K A Svensson; K M Merchant
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

9.  Human dopamine D1 receptor encoded by an intronless gene on chromosome 5.

Authors:  R K Sunahara; H B Niznik; D M Weiner; T M Stormann; M R Brann; J L Kennedy; J E Gelernter; R Rozmahel; Y L Yang; Y Israel
Journal:  Nature       Date:  1990-09-06       Impact factor: 49.962

10.  Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A.

Authors:  Patricia Di Ciano; Rachel J Underwood; Jim J Hagan; Barry J Everitt
Journal:  Neuropsychopharmacology       Date:  2002-06-18       Impact factor: 7.853

View more
  20 in total

Review 1.  Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.

Authors:  Amy E Moritz; R Benjamin Free; David R Sibley
Journal:  Cell Signal       Date:  2017-07-14       Impact factor: 4.315

Review 2.  What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?

Authors:  Mayako Michino; Thijs Beuming; Prashant Donthamsetti; Amy Hauck Newman; Jonathan A Javitch; Lei Shi
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 3.  Dopamine receptors - IUPHAR Review 13.

Authors:  Jean-Martin Beaulieu; Stefano Espinoza; Raul R Gainetdinov
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

4.  Dopamine receptor D4 promoter hypermethylation increases the risk of drug addiction.

Authors:  Huihui Ji; Xuting Xu; Guili Liu; Huifen Liu; Qinwen Wang; Wenwen Shen; Longhui Li; Xiaohu Xie; Haochang Hu; Lei Xu; Wenhua Zhou; Shiwei Duan
Journal:  Exp Ther Med       Date:  2017-12-12       Impact factor: 2.447

5.  Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonists.

Authors:  Jonathan O Witt; Andrea L McCollum; Miguel A Hurtado; Eric D Huseman; Daniel E Jeffries; Kayla J Temple; Hyekyung C Plumley; Anna L Blobaum; Craig W Lindsley; Corey R Hopkins
Journal:  Bioorg Med Chem Lett       Date:  2016-03-30       Impact factor: 2.823

6.  Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic study.

Authors:  Sergio De Filippis; Ilaria Cuomo; Georgios D Kotzalidis; Daniela Pucci; Pietro Zingaretti; Raffaella Porrari; Camilla Fini; Paola Motta; Matteo Caloro; Paolo Girardi
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-28

7.  Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans.

Authors:  Bernard Le Foll; Doris Payer; Patricia Di Ciano; Mihail Guranda; Shinichiro Nakajima; Junchao Tong; Esmaeil Mansouri; Alan A Wilson; Sylvain Houle; Jeff H Meyer; Ariel Graff-Guerrero; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2015-06-19       Impact factor: 7.853

8.  Proteome-Informed Machine Learning Studies of Cocaine Addiction.

Authors:  Kaifu Gao; Dong Chen; Alfred J Robison; Guo-Wei Wei
Journal:  J Phys Chem Lett       Date:  2021-11-09       Impact factor: 6.888

9.  Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling.

Authors:  Jessica L Smith; David A Stein; David Shum; Matthew A Fischer; Constantin Radu; Bhavneet Bhinder; Hakim Djaballah; Jay A Nelson; Klaus Früh; Alec J Hirsch
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

Review 10.  Catecholamines and cognition after traumatic brain injury.

Authors:  Peter O Jenkins; Mitul A Mehta; David J Sharp
Journal:  Brain       Date:  2016-06-02       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.